Hsu, Wan-Lun
Lee, Chieh-Ju
Coghill, Anna E.
Liu, Zhiwei
Yu, Kelly J.
Simon, Julia
Hildesheim, Allan
Waterboer, Tim
Taylor, Graham S.
Berzofsky, Jay A.
Wang, Cheng-Ping
Huang, Yi-Hsiang
Funding for this research was provided by:
Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics
National Science and Technology Council (104-2314-B-002 -160 -MY3)
Article History
Received: 14 November 2025
Accepted: 16 February 2026
First Online: 11 March 2026
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the National Taiwan University Hospital (approval number: 201412109RINB). Written informed consent was obtained from all participants prior to participation.
: Not applicable.
: The authors declare no competing interests. Dr. Zhiwei Liu is currently employed in Merck & Co, Inc. The views and opinions expressed in this article do not represent the views and opinions of any public or private entity (e.g., agency, government, organization, institution, or company).